|
|
|
MIRA INFORM REPORT
|
Report No. : |
512168 |
|
Report Date : |
31.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
501/B, Silver Utopia, Cardinal Gracious Road, Chakala, Andheri (East), Mumbai –
400069, Maharashtra |
|
Tel. No.: |
91-22-66974900 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
07.06.1988 |
|
|
|
|
Com. Reg. No.: |
11-141417 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 149.150 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U85195MH1988PTC141417 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Divulged |
|
|
|
|
TIN No: |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMA15848A |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACA0266H |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
|
|
|
|
|
No. of Employees
: |
Informational declined by management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January
2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated in the year 1988. It is a subsidiary of Roche
Pharmholding B.V. Netherlands. It is a biotech company engaged in pharmaceuticals and diagnostics
focusing on advancing science to improve people’s lives. As per the financial records of 2017, the company has reported a
decline in its revenue as compared to the previous year’s revenue but has
managed to maintain an average net profit margin of 3.10%. The company possesses sound financial position marked by healthy net
worth base along with comfortable liquidity parameter. Rating takes into consideration the company’s favourable earnings per
share (EPS) of INR 176.00 as against its face value (FV) of INR 100. Rating also takes into consideration the company’s long established
track record, strength that the company derives from its holding company and
its experienced management team. Business is active. Payment seems to be regular. In view of aforesaid, the company can be considered for business
dealings at usual trade terms and condition.
|
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 31.05.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED
Management non-cooperative (Tel No.: 91-22-66974900)
LOCATIONS
|
Registered/
Corporate Office : |
501/B, Silver Utopia, Cardinal Gracious Road, Chakala, Andheri (East), Mumbai –
400069, Maharashtra, India |
|
Tel. No.: |
91-22-66974900/ 66974969/ 6697 4986 |
|
Fax No.: |
91-22-56974921/ 66974909 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Regional Offices 1:
|
3rd Floor, Office Block, MGF Corporate Park, Metropolitan Mall, Plot No – A-2, District Centre, Saket, New Delhi – 110017, India |
|
Tel. No.: |
91-11-4603 4500 |
|
Fax No.: |
91-11-4603 4528 |
|
|
|
|
Regional Offices 2:
|
Sreyas, Chamiers Towers, 8th Floor, West Wing, New No. - 37, Old No. - 23 & 24, Chamiers Road, Tenyampet, Chennai – 600018, Tamilnadu, India |
|
Tel. No.: |
91-44-4390 0300 |
|
Fax No.: |
91-44-4211 9095 |
|
|
|
|
Regional Offices 3:
|
4th Floor, C-Block, 781, Anandpur, EM Bypass, Kolkata – 700107, West Bengal, India |
|
Tel. No.: |
91-33-4015 3700 |
|
Fax No.: |
91-33-4015 3701 |
|
|
|
|
Regional Offices 4:
|
1503, 15th Floor, The Capital, Plot No.C-70, Behind ICICI Bank, BKC Complex, Bandra (East), Mumbai – 400051, Maharashtra, India |
|
Tel. No.: |
91-22-33941414 |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Shravan Subramanyam |
|
Designation : |
Managing Director |
|
Address : |
New No.14, Old No.26, Rajasekaran Road, Mylapore, Chennai-600004, Tamilnadu, India |
|
Date of Birth/Age : |
01.01.1979 |
|
PAN No: |
APDPS7239H |
|
Qualification : |
MBBS |
|
Date of Appointment : |
31.08.2016 |
|
DIN No.: |
00695586 |
|
|
|
|
Name : |
Gottlieb Andrea Keller |
|
Designation : |
Director |
|
Address : |
Englischviertelstrasse 21, Zurich – 8032, Switzerland |
|
Date of Birth/Age : |
08.08.1954 |
|
Qualification : |
University of Basel (law and economics), |
|
Date of Appointment : |
25.11.2008 |
|
DIN No.: |
02403286 |
|
|
|
|
Name : |
Mr. Brajesh Rameshwardas Daga |
|
Designation : |
Director |
|
Address : |
C-1201, Lavender, Mahindra Splendour, L B S Road, Opposite Metro Mall, Bhandup (West), Mumbai – 400078, Maharashtra India |
|
Date of Birth/Age : |
01.09.1972 |
|
PAN No: |
ABQPD5473P |
|
Qualification : |
CS,ACA,ICWA |
|
Date of Appointment : |
01.04.2016 |
|
DIN No.: |
02349092 |
|
|
|
|
Name : |
Mr. Lars Guido Sander |
|
Designation : |
Director |
|
Address : |
Ghia Mansion, 2nd Floor, M. L. Dhanukar Road, Carmichael Road, Mumbai – 400026, Maharashtra, India |
|
Date of Birth/Age : |
20.06.1965 |
|
Qualification : |
Business Economics Marketing and Trade |
|
PAN No: |
EZRPS9042B |
|
Date of Appointment : |
29.04.2013 |
|
DIN No.: |
06589221 |
|
|
|
|
Name : |
Lara Yumi Tsuji Bezerra |
|
Designation : |
Additional Director |
|
Address : |
Mansion Escondida Kemal Atatürk Street, Ppl Residential Valle Arr Iba Boliva Caracas 1061 Venezuela |
|
Date of Appointment : |
23.11.2017 |
|
DIN No.: |
07975138 |
KEY EXECUTIVES
|
Name : |
Mr. Brajesh Rameshwardas Daga |
|
Designation : |
Company Secretory |
|
Address : |
C-1201, Lavender, Mahindra Splendour, L. B. S Road, Opposite Metro Mall, Bhandup (West), Mumbai – 400078, Maharashtra India |
|
Date of Birth/Age : |
01.09.1972 |
|
PAN No: |
ABQPD5473P |
|
Date of Appointment : |
01.04.2016 |
|
|
|
|
Name : |
Manish Ghia and Associates |
|
Designation : |
Company Secretory |
|
Address : |
4, Chandan Niwas (Old), M.V. Road, Off Andheri Kurla Road, Opposite Vishal Hall, Andheri (East), Mumbai – 400069, Maharashtra, India |
|
Tel. No: |
91-22-26826286/ 26815400 |
|
Email: |
MAJOR SHAREHOLDERS
As on: 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Roche Pharmholding B. V., Netherland |
|
1491501 |
|
Roche Chemical Establishment Limited, Switzerland |
|
01 |
|
Total |
|
1491502 |
Equity Share Break up (Percentage of Total Equity)
As on: 08.09.2017
|
Category |
Percentage |
|
Promoters - Body
corporate |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
|
||||
|
|
|
||||
|
Products/ Service: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
B.S.R and Company Chartered Accountants |
|
Address : |
5th Floor, Lodha Excellus Apollo Mills Compound, N M Joshi Marg, Mahalaxmi, Mumbai – 400011, Maharashtra, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AAAFB9852F |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding Company : |
Roche Pharmholding B.V., Netherlands |
|
|
|
|
Ultimate Holding
Company: |
Roche Holdings Limited, Basel |
|
|
|
|
Fellow Subsidiary
Company: |
|
CAPITAL STRUCTURE
AS ON 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1800000 |
Equity Shares |
INR 100/- each |
INR 180.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1491502 |
Equity Shares |
INR 100/- each |
INR 149.150
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
149.150 |
149.150 |
149.150 |
|
(b) Reserves and Surplus |
2945.198 |
2644.908 |
2287.426 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
3094.348 |
2794.058 |
2436.576 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long-term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
95.287 |
112.012 |
75.205 |
|
Total Non-current
Liabilities (3) |
95.287 |
112.012 |
75.205 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
1022.931 |
693.555 |
735.762 |
|
(b) Trade
payables |
1761.289 |
1733.043 |
1467.013 |
|
(c) Other
current liabilities |
464.057 |
580.465 |
459.191 |
|
(d) Short-term
provisions |
180.202 |
171.684 |
199.684 |
|
Total Current
Liabilities (4) |
3428.479 |
3178.747 |
2861.650 |
|
|
|
|
|
|
TOTAL |
6618.114 |
6084.817 |
5373.431 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i) Tangible
assets |
2992.824 |
2515.115 |
2212.890 |
|
(ii)
Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Tangible assets
capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
729.297 |
631.236 |
475.379 |
|
(d)
Long-term loans and advances |
157.550 |
125.256 |
122.955 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
3879.671 |
3271.607 |
2811.224 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
2349.038 |
2336.414 |
1935.836 |
|
(c) Trade
receivables |
355.498 |
400.027 |
489.488 |
|
(d) Cash and
bank balances |
0.630 |
1.185 |
1.032 |
|
(e)
Short-term loans and advances |
32.781 |
75.216 |
135.499 |
|
(f) Other
current assets |
0.496 |
0.368 |
0.352 |
|
Total
Current Assets |
2738.443 |
2813.210 |
2562.207 |
|
|
|
|
|
|
TOTAL |
6618.114 |
6084.817 |
5373.431 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Total
Revenue from operations |
8463.629 |
9068.332 |
7709.826 |
|
|
Other Income |
40.929 |
1.209 |
1.865 |
|
|
TOTAL |
8504.558 |
9069.541 |
7711.691 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Purchases of
Stock-in-Trade |
5041.641 |
5443.179 |
4846.114 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(4.877) |
(219.643) |
(265.577) |
|
|
Employee benefit expense |
796.171 |
888.830 |
758.957 |
|
|
CSR expenditure |
1.906 |
1.016 |
0.000 |
|
|
Other expenses |
1081.387 |
1420.087 |
1186.204 |
|
|
TOTAL |
6916.228 |
7533.469 |
6525.698 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
1588.330 |
1536.072 |
1185.993 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
78.884 |
67.300 |
82.137 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
1509.446 |
1468.772 |
1103.856 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
1083.746 |
913.887 |
769.154 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
425.700 |
554.885 |
334.702 |
|
|
|
|
|
|
|
Less |
TAX |
163.631 |
197.404 |
114.376 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
262.069 |
357.481 |
220.326 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
334.662 |
412.289 |
344.301 |
|
|
Commission (excluding service tax) |
27.304 |
22.211 |
28.688 |
|
|
TOTAL EARNINGS |
361.966 |
434.500 |
372.989 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Capital Goods |
5793.229 |
5697.043 |
5061.278 |
|
|
TOTAL IMPORTS |
5793.229 |
5697.043 |
5061.278 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
175.71 |
239.68 |
147.72 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
1568.378 |
1699.715 |
1444.232 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
1282.941 |
1335.863 |
1241.859 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days [Sundry Debtors / Income * 365] |
|
15.33 |
16.10 |
23.17 |
|
|
|
|
|
|
|
Account Receivables Turnover [Income / Sunday Debtors] |
|
23.81 |
22.67 |
15.75 |
|
|
|
|
|
|
|
Average Payment Days [Sundry Creditors /
Purchases * 365] |
|
127.51 |
116.21 |
110.49 |
|
|
|
|
|
|
|
Inventory Turnover [Operating Income /
Inventories] |
|
0.68 |
0.66 |
0.61 |
|
|
|
|
|
|
|
Asset Turnover [Operating Income / Net Fixed
Assets] |
|
0.53 |
0.61 |
0.54 |
LEVERAGE RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio [(Borrowing + Current Liabilities) / Total Assets] |
|
0.52 |
0.52 |
0.53 |
|
|
|
|
|
|
|
Debt Equity Ratio (Borrowings / NetWorth) |
|
0.33 |
0.25 |
0.30 |
|
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities
/ NetWorth) |
|
1.11 |
1.14 |
1.17 |
|
|
|
|
|
|
|
Fixed Assets to NetWorth (Net Fixed Assets /
NetWorth) |
|
0.97 |
0.90 |
0.91 |
|
|
|
|
|
|
|
Interest Coverage Ratio [PBIT / Financial
Charges] |
|
20.14 |
22.82 |
14.44 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin [(PAT / Sales) * 100] |
(%) |
3.10 |
3.94 |
2.86 |
|
|
|
|
|
|
|
Return on Total Assets [(PAT / Total Assets)
* 100] |
(%) |
3.96 |
5.87 |
4.10 |
|
|
|
|
|
|
|
Return on Investment (ROI) [(PAT / NetWorth)
* 100] |
(%) |
8.47 |
12.79 |
9.04 |
SOLVENCY RATIO
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio [Current Assets / Current Liabilities] |
|
0.80 |
0.89 |
0.90 |
|
|
|
|
|
|
|
Quick Ratio [(Current Assets - Inventories)
/ Current Liabilities] |
|
0.11 |
0.15 |
0.22 |
|
|
|
|
|
|
|
G-Score Ratio Financial [NetWorth / Total
Assets] |
|
0.47 |
0.46 |
0.45 |
|
|
|
|
|
|
|
G-Score Ratio Debt [Debts / Equity Capital] |
|
6.86 |
4.65 |
4.93 |
|
|
|
|
|
|
|
G-Score Ratio Liquidity [Total Current
Assets / Total Current Liabilities] |
|
0.80 |
0.89 |
0.90 |
Total Liability = Short-term
Debt + Long-term Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
149.150 |
149.150 |
149.150 |
|
Reserves & Surplus |
2287.426 |
2644.908 |
2945.198 |
|
Net
worth |
2436.576 |
2794.058 |
3094.348 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
735.762 |
693.555 |
1022.931 |
|
Total
borrowings |
735.762 |
693.555 |
1022.931 |
|
Debt/Equity
ratio |
0.302 |
0.248 |
0.331 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
7709.826 |
9068.332 |
8463.629 |
|
|
|
17.620 |
(6.668) |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
7709.826 |
9068.332 |
8463.629 |
|
Profit/ (Loss) |
220.326 |
357.481 |
262.069 |
|
|
2.86
% |
3.94
% |
3.10
% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
No |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
Note: The Registered Office of the company has been shifted from “761, Solitaire Corporate Park, Andheri Ghatkopar Link Road, Andheri (East), Mumbai – 400093, Maharashtra, India ” to the present address w.e.f. 21.04.2008.
INDEX OF CHARGES: NO
CHARGES EXISTS FOR COMPANY
UNSECURED LOANS
|
PARTICULARS |
31.03.2017 (INR
In Million) |
31.03.2016 (INR
In Million) |
|
SHORT TERM BORROWINGS |
|
|
|
Loans repayable on demand from others |
1022.931 |
693.555 |
|
|
|
|
|
Total |
1022.931 |
693.555 |
COMPANY OVERVIEW
The Company is a part of the diagnostics division of the Roche group, which is a 100% subsidiary of Roche Pharmholding B.V., The Netherlands. Roche Pharmholding B.V., The Netherlands is a key player in the pharmaceuticals business in the world. The Company was incorporated as AVL Biomedical Private Limited on 7 June 1988, which was a subsidiary of AVL Medical Instrumentation AG. The name of this company (AVL Biomedical Private Limited) was subsequently changed to Roche Diagnostics India Private Limited on 23 August 2002.
The Company is engaged in distribution, marketing and sale of Medical diagnostic Products/equipments, reagents, consumable and spares and also provides after sale service for equipments. The Company caters to domestics and international markets.
During the year, the Company has completed the demerger of its diabetes care business into Roche Diabetes Care India Private Limited. The Diabetes care business is presented as a discontinued operation in the accompanying financial statements.
FIXED ASSETS:
Tangible Assets
·
Plant and Equipment
·
Furniture and Fixtures
·
Office Equipment
· Leasehold Improvements
CMT REPORT (Corruption, Money Laundering
& Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 67.83 |
|
|
1 |
INR 89.70 |
|
Euro |
1 |
INR 78.20 |
INFORMATION DETAILS
|
Information
Gathered by : |
SVT |
|
|
|
|
Analysis Done by
: |
NYT |
|
|
|
|
Report Prepared
by : |
MTN |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.